Resource Center
Peanut allergy is one of the most common food allergies, affecting approximately 1% of the US population [1], and the prevalence of peanut allergy is thought to be increasing [2]. In allergic individuals, anaphylaxis following exposure to peanuts can be fatal, requiring these individuals to carry epinephrine injectors at all times. Perhaps due to the serious nature of peanut allergies and its wide recognition, as many as 3 in 4 individuals are misdiagnosed as having peanut allergies [3], when in fact they have either asymptomatic to mild peanut sensitization or no sensitization at all.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.